Clinical Trials

Trials are being held to evaluate the efficacy of HSCT for MS. 

StarMS research study

StarMS aims to compare the efficacy and safety profile of aHSCT vs ‘highly effective’ DMTs – Ocrelizumab and Alemtuzumab. The study will also research the mechanism of action to help our understanding of how aHSCT works in RRMS.

Read More